Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
UTHSC (The University of Tennessee Health Science Center) College of Pharmacy shared a post on LinkedIn:
“Congratulations to Dr. Bhupesh Singla, Assistant Professor in the College of Pharmacy’s Department of Pharmaceutical Sciences, who has been elected as a Fellow of the American Heart Association (FAHA) by the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
This prestigious honorary title is awarded to physicians, scientists, nurses, and healthcare professionals who have demonstrated a sustained record of excellence and made significant contributions to cardiovascular and stroke research, clinical practice, education, and leadership.
Dr. Singla’s research investigates the role of matricellular proteins in the development and progression of cardiometabolic diseases, including atherosclerosis and metabolic dysfunction-associated steatotic liver disease.
Election as an FAHA recognizes Dr. Singla’s scientific distinction and expertise in cardiovascular research.
His research work has been published in high-impact journals, and he has a strong and consistent record of securing funding for basic science research, including a predoctoral fellowship, two postdoctoral fellowships, an NIH K99/R00 award, an NIH R01 grant, and several institutional intramural grants.
In addition to his research achievements, Dr. Singla is committed to mentoring trainees and actively contributes to service at the institutional, national, and international levels.
‘I am deeply honored to be elected as a Fellow of the American Heart Association,’ said Dr. Singla. ‘This recognition reflects the collective efforts and dedication of my trainees, collaborators, and mentors.’
The AHA is a leading voluntary health organization devoted to fighting cardiovascular disease and stroke.
Fellowship in the AHA recognizes not only scientific accomplishments but also dedication to the organization’s mission to build healthier lives free of cardiovascular disease and stroke.”
Stay updated with Hemostasis Today.
-
May 16, 2026, 16:26Tagreed Alkaltham: Why Can Some Apheresis Donors Donate More Frequently?
-
May 16, 2026, 16:26Living with Hemophilia Looks Very Different Today Than It Did Decades Ago – UNC Health
-
May 16, 2026, 16:23Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference – RFHMO
-
May 16, 2026, 16:22Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
-
May 16, 2026, 16:20Abdallah Othman: Exploring the Detailed Diagram of the Coronary Arteries
-
May 16, 2026, 16:16The Minute That Saved a Life – Elle’s Battle with a Dismissed Blood Clot – National Blood Clot Alliance
-
May 16, 2026, 16:07Pathophysiology of Impaired Hemostasis in GT – Glanzmann’s Research Foundation
-
May 16, 2026, 16:05Ifeanyichukwu Ifechidere: The Overlooked Diagnosis of VWD in Young Girls With Menorrhagia
-
May 16, 2026, 16:04How We Assess Coagulation in Patients on FXa Inhibitors and What May Come Next – Vasculearn Network